Cargando…

Cancer Susceptibility Candidate 9 (CASC9): A Novel Targetable Long Noncoding RNA in Cancer Treatment

Based on epidemiological data provided by the World Health Organization (2018), cancer is the second most prevalent cause of death worldwide. Several factors are thought to contribute to the high mortality rate in cancer patients, including less-than-optimal diagnostic and therapeutic strategies. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Uttam, Barwal, Tushar Singh, Acharya, Varnali, Tamang, Suraksha, Vasquez, Karen M., Jain, Aklank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2020
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256364/ https://www.ncbi.nlm.nih.gov/pubmed/32450549 http://dx.doi.org/10.1016/j.tranon.2020.100774

Ejemplares similares

SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019)

Long Non-Coding RNAs as Strategic Molecules to Augment the Radiation Therapy in Esophageal Squamous Cell Carcinoma
por: Sharma, Uttam, et al.
Publicado: (2020)

MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers
por: Barwal, Tushar Singh, et al.
Publicado: (2021)

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
por: Khandelwal, Akanksha, et al.
Publicado: (2021)

Evolution of Frozen Section in Carcinoma Breast: Systematic Review
por: Rana, Manjit Kaur, et al.
Publicado: (2022)

The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer
por: Pan, Zhiwen, et al.
Publicado: (2016)

Current Trends of Carcinoma: Experience of a Tertiary Care Cancer Center in North India
por: Rana, Manjit K, et al.
Publicado: (2021)

Cancer Susceptibility Candidate 9 (CASC9) Promotes Colorectal Cancer Carcinogenesis via mTOR-Dependent Autophagy and Epithelial–Mesenchymal Transition Pathways
por: Islam Khan, Md Zahirul, et al.
Publicado: (2021)

The imminent role of microRNAs in salivary adenoid cystic carcinoma
por: Kumar, Pawan, et al.
Publicado: (2022)

Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study
por: Sharma, Uttam, et al.
Publicado: (2022)

A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response
por: Sharma, Uttam, et al.
Publicado: (2022)

Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma
por: Zhou, Jianlong, et al.
Publicado: (2018)

Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR‐488‐3p
por: Chen, Yonghui, et al.
Publicado: (2020)

Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer
por: Ding, Yuansheng, et al.
Publicado: (2020)

Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR
por: Zhang, Xudong, et al.
Publicado: (2020)

Long noncoding RNA CASC9/miR‐519d/STAT3 positive feedback loop facilitate the glioma tumourigenesis
por: Liu, Hongjiang, et al.
Publicado: (2018)

Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer [Retraction]
Publicado: (2020)

CASC15 polymorphisms are correlated with cervical cancer susceptibility in Chinese women
por: Gao, Ziying, et al.
Publicado: (2020)

LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer
por: Luo, Kaili, et al.
Publicado: (2019)

Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy
por: Jiao, Yingwei, et al.
Publicado: (2021)

DHX9 helicase is involved in preventing genomic instability induced by alternatively structured DNA in human cells
por: Jain, Aklank, et al.
Publicado: (2013)

Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2017)

Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study
por: Uttam, Vivek, et al.
Publicado: (2023)

Downregulation of long noncoding RNA CASC15 inhibits progression, migration and invasion of papillary thyroid cancer
por: Li, Xiaoyu, et al.
Publicado: (2019)

Retracted: Changes and Prognostic Value of lncRNA CASC9 in Patients with Advanced Colon Cancer after Chemotherapy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Emerging neo adjuvants for harnessing therapeutic potential of M1 tumor associated macrophages (TAM) against solid tumors: Enusage of plasticity
por: Nadella, Vinod, et al.
Publicado: (2020)

Correction: Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance
por: Shang, Chao, et al.
Publicado: (2022)

Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer
por: Noriega-Rivera, Ricardo, et al.
Publicado: (2022)

Clinicopathological association and prognostic value of long non-coding RNA CASC9 in patients with cancer: A meta-analysis
por: Duan, Hou-Yu, et al.
Publicado: (2020)

Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes
por: Wang, Linxia, et al.
Publicado: (2018)

Standardization of Manual Method of Immunohistochemical Staining for Breast Cancer Biomarkers at Tertiary Cancer Care Center: An Audit
por: Rana, Manjit K, et al.
Publicado: (2022)

Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma
por: Sassenberg, Madeleine, et al.
Publicado: (2019)

The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer
por: Malhotra, Akshay, et al.
Publicado: (2017)

Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma
por: Zeng, Yong-Lian, et al.
Publicado: (2019)

A review on the role of CASC11 in cancers
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2023)

Long non-coding RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes nephropathy
por: Li, Feng, et al.
Publicado: (2020)

Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK
por: Zhang, Heping, et al.
Publicado: (2022)

An innovative CASC training redesign – ‘experience of virtual mock CASC exam’
por: Rankin, Jennifer, et al.
Publicado: (2021)

Association between CASC16 rs4784227 polymorphism and breast cancer susceptibility: A meta-analysis
por: Liang, Xiong-Shun, et al.
Publicado: (2021)

Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
por: Chen, Zhenyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lu8m4csidb06j3fbiavsmtfb5m